Compare LEXX & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | YCBD |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 13.5M |
| IPO Year | N/A | N/A |
| Metric | LEXX | YCBD |
|---|---|---|
| Price | $0.70 | $1.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.50 | ★ $2.00 |
| AVG Volume (30 Days) | 1.5M | ★ 32.3M |
| Earning Date | 01-13-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $705,923.00 | ★ $19,190,468.00 |
| Revenue This Year | $13.35 | $6.94 |
| Revenue Next Year | $78.83 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 52.05 | N/A |
| 52 Week Low | $0.46 | $0.47 |
| 52 Week High | $2.43 | $6.54 |
| Indicator | LEXX | YCBD |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 47.47 |
| Support Level | $0.46 | $1.00 |
| Resistance Level | $0.72 | $1.32 |
| Average True Range (ATR) | 0.10 | 0.33 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 58.20 | 6.43 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.